A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers

Sarkis Hamalian(California State University, Northridge), Jonathan A. Kelber(Baylor University), Julia Tchou(University of Pennsylvania), Francesca Sanchez(California State University, Northridge), Eric Vickers(California State University, Northridge), Farhana Runa(California State University, Northridge), Tuan M. Nguyen(University of Virginia), Robert Güth(California State University, Northridge), Jonathan D. Humphries(Manchester Metropolitan University), Joshua Gamez(California State University, Northridge), Anupma Nayak(University of Pennsylvania), Megan J. Agajanian(California State University, Northridge), Martin J. Humphries(Wellcome Centre for Cell-Matrix Research), Justin Molnar(California State University, Northridge), Ioannis K. Zervantonakis(University of Pittsburgh)
Oncogene
July 8, 2021
Cited by 30


Related Papers